Inaticabtagene autoleucel Injection

DRUG3 trials

Sponsors

Juventas Cell Therapy Ltd.

Conditions

AIHA - Cold Autoimmune Hemolytic AnemiaAutoimmune ThrombocytopeniaB-cell Tumors

Phase 1

Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia

RecruitingNCT06826430

Juventas Cell Therapy Ltd.Autoimmune Thrombocytopenia

Start: 2025-03-01End: 2027-12-31Target: 12Updated: 2025-08-07

Inaticabtagene Autoleucel Injection in the Treatment of Autoimmune Hemolytic Anemia After Three or More Lines of Therapy

Not yet recruitingNCT07091370

Juventas Cell Therapy Ltd.AIHA - Cold Autoimmune Hemolytic Anemia

Start: 2025-12-27End: 2028-03-30Target: 12Updated: 2025-09-22

Unknown Phase

Long-term Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection

RecruitingNCT06461351

Juventas Cell Therapy Ltd.B-cell Tumors

Start: 2024-03-30End: 2040-03-30Target: 1000Updated: 2025-08-07